CEO Pascal Soriot says AstraZeneca is growing 'new branches' as Covid vaccine sales continue to fall
AstraZeneca CEO Pascal Soriot has been “pruning the tree” for quite some time, cutting a slate of unwanted programs across a range of indications over the last few quarters. And though the chief executive revealed two new cuts on Friday, he said he’s just about ready to put the clippers down and focus on “trying to grow new branches.”
Soriot expects the next couple of years to be “extremely rich in clinical results,” with more than 20 Phase III readouts slated for next year.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.